Press Release Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 29 minutes ago
Press Release Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates Aug 6
Press Release Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates Jul 30